Načítá se...
PYY(3–36) and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans
OBJECTIVE: Peptide YY(3–36) (PYY(3–36)), a Y2 receptor agonist, and oxyntomodulin, a glucagon-like peptide 1 (GLP-1) receptor agonist, are cosecreted by intestinal L-cells after each meal. Separately each hormone acts as an endogenous satiety signal and reduces appetite in humans when infused intrav...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Diabetes Association
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2889762/ https://ncbi.nlm.nih.gov/pubmed/20357366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db09-1859 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|